Cargando…
Intraperitoneal administration of nesfatin-1 stimulates glucagon-like peptide-1 secretion in fasted mice
Increasing endogenous secretion of glucagon-like peptide (GLP)-1 is considered a promising therapeutic approach for type 2 diabetes because decreased GLP-1 plasma concentrations have been observed in patients with this condition. Nesfatin-1, which is a central and peripheral anorexigenic peptide, ha...
Autores principales: | Tagawa, Noriko, Ogura, Honoka, Miyawaki, Hikaru, Asakawa, Akihiro, Kato, Ikuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685253/ https://www.ncbi.nlm.nih.gov/pubmed/36367173 http://dx.doi.org/10.3892/mmr.2022.12894 |
Ejemplares similares
-
Reduction in Nesfatin-1 Levels in the Cerebrospinal Fluid and Increased Nigrostriatal Degeneration Following Ventricular Administration of Anti-nesfatin-1 Antibody in Mice
por: Chen, Huanhuan, et al.
Publicado: (2021) -
Glucagon-like Peptide-1 Receptor in the Human Hypothalamus Is Associated with Body Mass Index and Colocalizes with the Anorexigenic Neuropeptide Nucleobindin-2/Nesfatin-1
por: Psilopanagioti, Aristea, et al.
Publicado: (2022) -
Pharmacokinetics of glucagon after intravenous, intraperitoneal and subcutaneous administration in a pig model
por: Teigen, Ingrid Anna, et al.
Publicado: (2022) -
Tissue-Specific Modulation of Gluco- and Growth-Regulatory Factor Abundance by Nesfatin-1 and Nesfatin-1-like Peptide in Goldfish
por: Rajeswari, Jithine Jayakumar, et al.
Publicado: (2023) -
Acute administration of interleukin‐6 does not increase secretion of glucagon‐like peptide‐1 in mice
por: Christiansen, Charlotte B., et al.
Publicado: (2018)